Evaluation of reactive oxygen metabolites in patients with non-small cell lung cancer after chemotherapy

Multidisciplinary Respiratory Medicine

Volumn 9, Issue 1, 2014, Pages

  Wakabayashi, Toru ^a   Kawashima, Tatsuo ^a   Matsuzawa, Yasuo ^a  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

Chemotherapy; Lung cancer; Oxidative stress; Reactive oxygen metabolites; Reactive oxygen species

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; PACLITAXEL; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OXIDATIVE STRESS; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84942986387     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-9-44     Document Type: Article

References (23)

1. Mantovani G, Maccio A, Madeddu C., Mura L, Gramignano G, Lusso M.R., Mulas C., Mudu MC, Murgia V, Camboni P, Massa E., Ferreli L, Contu P, Rinaldi A., Sanjust E, Atzei D, Elsener B: Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. Int J Cancer 2002, 98:84-91.
2. Mantovani G, Macciò A, Lai P, Massa E, Ghiani M, Santona MC: Cytokine activity in cancer related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Semin Oncol 1998, 25:45-52.
3. Bakan N, Taysi S, Yilmaz O., Bakan E, Kuskay S, Uzun N., Gundogdu M: Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. Clin Chim Acta 2003, 338:143-149.
4. Look MP, Musch E: Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy 1994, 40:8-15.
5. Sugihara K, Nakano S, Gemba M: Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex. Jpn J Pharmacol 1987, 44:71-76.
6. Sangeetha P, Das UN, Koratkar R, Suryaprabha P: Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med 1990, 8:15-19.
7. Takahashi K, Takita T, Umezawa H: Generation of superoxide anion by the reaction of bleomycin-Cu (II) with cysteine. Jpn J Antibiot 1987, 40:735-758.
8. Torun M, Yardim S, Gönenç A, Sargin H, Menevşe A, Símşek BT: Serum beta-carotene, vitamin E, vitamin C and malondialdehyde levels in several types of cancer. J Clin Pharm Ther 1995, 20:259-263.
9. Carratelli M, Porcaro L, Ruscica M., De Simone E, Bertelli AAE, Corsi MM: Reactive oxygen metabolites and prooxidant status in children with Down's syndrome. Int J Clin Pharm Res 2001, 21:79-84.
10. Trotti R, Carratelli M, Barbieri M., Micieli G, Bosone D, Rondanelli M., Bo P: Oxidative stress and a thrombophilic condition in alcoholics without severe liver disease. Haematologica 2001, 86:85-91.
11. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 1997, 111:1710-1717.
12. Therasse P, Arbuck SG, Eisenhauer E.A., Wanders J., Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205-216.
13. Toyokuni S, Okamoto K, Yodoi J., Hiai H: Persistent oxidative stress cancer. FEBS Lett 1995, 358:1-3.
14. Szatrowski TP, Nathan CF: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991, 51:794-798.
15. Sato K, Ito K, Kohara H., Yamaguchi Y, Adachi K, Endo H: Negative regulation of catalase gene expression in hepatoma cells. Mol Cell Biol 1992, 12:2525-2533.
16. Sun Y: Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 1990, 8:583-599.
17. Inokuma T, Haraguchi M, Fujita F., Tajima Y, Kanematsu T: Oxidative stress and tumor progression in colorectal cancer. Hepatogastroenterology 2009, 56:343-347.
18. Gerardi G, Usberti M, Martini G., Albertini A, Sugherini L, Pompella A., Di LD: Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med 2002, 40:104-110.
19. Noda N, Wakasugi H: Cancer and oxidative stress. JMAJ 2001, 44:535-539.
20. Ridker PM, Brown NJ, Vaughan D.E., Harrison DG, Mehta JL: Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004, 109:IV-6-IV-19.
21. Rider PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363-369.
22. Cesarone MR, Belcaro G, Carratelli M., Cornelli U, De Sanctis MT, Incandela L, Barsotti A, Terranova R., Nicolaides A: A simple test to monitor oxidative stress. Int Angiol 1999, 18:127-130.
23. Cornelli U, Terranova R, Luca S., Cornelli M, Alberti A: Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr 2001, 131:3208-3221.